

Health Care: Drugs
Trubion Pharmaceuticals Inc. (TRBN: NASDAQ)
$4.60 0.06 | 1.32%
10/28/10 - 03:59 PM ET
Portfolios with TRBN
Latest TRBN Headlines from TheStreet
More Financial News for TRBN
Press Releases for TRBN
- Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Trubion Pharmaceuticals, Inc. And Its Board Of Directors - Business Wire 10.05.10 | 11:10 am
- Law Office Of Abe Shainberg Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. In Connection With Sale To Emergent BioSolutions Inc. - TRBN - Business Wire 08.17.10 | 04:08 pm
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Trubion Pharmaceuticals, Inc. - Business Wire 08.16.10 | 01:08 pm
- The Law Office Of Vincent Wong Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. - TRBN - Business Wire 08.16.10 | 11:08 am
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Trubion Pharmaceuticals, Inc. - Business Wire 08.13.10 | 08:08 pm
- Ryan & Maniskas, LLP Announces Investigation Of Trubion Pharmaceuticals, Inc. - Business Wire 08.13.10 | 04:08 pm
- Kendall Law Group Investigates Trubion Pharmaceuticals, Inc. Acquisition For Shareholders - Business Wire 08.13.10 | 04:08 pm
- The Briscoe Law Firm, PLLC And Cash Powers Taylor, LLP Announce The Investigation Of Possible Breaches Of Fiduciary Duties Concerning The Acquisition Of Trubion Pharmaceuticals, Inc. - Business Wire 08.13.10 | 12:08 pm
- The Law Office Of Joseph Klein Announces Investigation Of Possible Breach Of Fiduciary Duty By The Board Of Trubion Pharmaceuticals Inc. - TRBN - Business Wire 08.13.10 | 12:08 pm
- Robbins Umeda LLP Announces An Investigation Of The Acquisition Of Trubion Pharmaceuticals, Inc. By Emergent Biosolutions Inc. - Business Wire 08.12.10 | 11:08 pm
See All Press Releases
Partner Headlines for TRBN